摘要
视网膜静脉阻塞(retinal vein occlusion,RVO)是一种常见的视网膜血管疾病,对于该病的病因及治疗方面一直存在很多争议。近年来对于该病的分型、病因及治疗都有了一些新的研究,尤其是玻璃体腔注射曲安奈德和抗VEGF药物在治疗患者黄斑水肿,提高患者视力上有较好的疗效,将可能成为治疗RVO有效的选择。
Retinal vein occlusion(RVO)is a common vascular disease of the retina,yet its pathogenesis and treatment remain very controversial.In recent years,there have been some new understanding about the disease,for example,the classification and pathogenesis,and especially in the therapy of the intravitreal injection of triamcinolone acetonide as well as anti-VEGFs.They can improve visual acuity and treat macular edema effectively.Consequently,they are probably becoming new options for the treatment of RVO.
出处
《国际眼科杂志》
CAS
2012年第1期77-80,共4页
International Eye Science
关键词
视网膜静脉阻塞
分型
病因
治疗
retinal vein occlusion
classification
pathogenesis
therapeutics